Schwetz, Switzerland

Robert F A Escher

This inventor holds 1 USPTO granted patent. Top assignee: Asat Ag Applied Science & Technology. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert F A Escher. Retrieved from https://idiyas.com/inventor/robert-f-a-escher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Robert F A Escher: Innovator in Antibody Technology

Introduction

Robert F A Escher is a notable inventor based in Schwetz, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. His work focuses on innovative solutions that address critical health issues.

Latest Patents

Robert F A Escher holds a patent for "Anti-GPIIb/IIIa recombinant antibodies." This invention relates to novel nucleic acid sequences that encode human autoantibodies and antiidiotypic antibodies against blood platelet membrane proteins. It also includes novel amino acid sequences of human antibodies and their use for the diagnosis and therapy of diseases. He has 1 patent to his name.

Career Highlights

Escher is associated with Asat AG Applied Science & Technology, where he applies his expertise in antibody technology. His work has been instrumental in advancing therapeutic options for various medical conditions.

Collaborations

One of his notable collaborators is Peter Berchtold, with whom he has worked on various projects related to antibody development.

Conclusion

Robert F A Escher's contributions to the field of biotechnology, particularly in antibody technology, highlight his role as an innovator. His work continues to impact the medical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…